Disclosures for "Glucose Metabolism of the Cerebellum in Temporal Lobe Epilepsy with Hippocampal Sclerosis"
-
Mr. CHAO has nothing to disclose.
-
The institution of Dr. Peng has received research support from NIH. The institution of Dr. Peng has received research support from MJFF.
-
Dr. Chou has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Chou has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Yu has nothing to disclose.